Truerelief
TrueRelief is a company dedicated to providing non-opioid, non-invasive neuromodulation devices for pain management, inflammation reduction, and wound healing. Their proprietary electrical configuration and unique probe delivery system make their treatment unlike any other electrical therapy, aiming to reduce opioid usage and manage pain effectively under the supervision of healthcare professionals.
Industries
Nr. of Employees
small (1-50)
Truerelief
100 Wilshire Blvd Suite 700, Santa Monica, CA 90401
Patents
Products
Non‑invasive probe‑based bioelectronic neuromodulation device
A clinician‑administered electroceutical device that delivers high‑frequency pulsed direct current through dynamically operated probe electrodes for localized pain relief, inflammation reduction, and adjunctive post‑operative therapy.
Non‑invasive probe‑based bioelectronic neuromodulation device
A clinician‑administered electroceutical device that delivers high‑frequency pulsed direct current through dynamically operated probe electrodes for localized pain relief, inflammation reduction, and adjunctive post‑operative therapy.
Services
Provision of in‑clinic, clinician or technician‑delivered neuromodulation treatments for acute and chronic pain and post‑operative management under healthcare professional supervision.
Distribution of a treatment protocol manual covering common pain conditions and guidance on treatment durations, frequencies, and clinical workflows; training materials provided to healthcare professionals.
Provision of veterinary‑specific treatment protocols for pain, inflammation reduction, and wound healing, with case documentation including infrared imaging examples.
Collaborative pilot studies and implementation partnerships with health system divisions and physical therapy networks to evaluate clinical outcomes and system‑level utilization.
Provision of in‑clinic, clinician or technician‑delivered neuromodulation treatments for acute and chronic pain and post‑operative management under healthcare professional supervision.
Distribution of a treatment protocol manual covering common pain conditions and guidance on treatment durations, frequencies, and clinical workflows; training materials provided to healthcare professionals.
Provision of veterinary‑specific treatment protocols for pain, inflammation reduction, and wound healing, with case documentation including infrared imaging examples.
Collaborative pilot studies and implementation partnerships with health system divisions and physical therapy networks to evaluate clinical outcomes and system‑level utilization.
Expertise Areas
- Bioelectronic therapeutics
- Clinical trial design and execution (sham‑controlled randomized trials)
- Acute and chronic pain management
- Veterinary therapeutic protocols
Key Technologies
- High‑frequency (20 kHz) pulsed direct‑current neuromodulation
- Probe‑based electrode delivery system
- Electroceutical/bioelectronic therapeutic methods
- In vitro assays and in vivo rodent models
News & Updates
TrueRelief will conclude a 156-subject, sham-controlled clinical trial in Fall 2023 to evaluate its effectiveness in managing post-op pain for bariatric surgery patients.
A two-year peer-reviewed study published in 2022 exploring the mechanism of action of TrueRelief in reducing inflammation and relieving pain.
TrueRelief was awarded a $244,000 federal grant from the Health & Human Services Department to support its development and validation.
TrueRelief will conclude a 156-subject, sham-controlled clinical trial in Fall 2023 to evaluate its effectiveness in managing post-op pain for bariatric surgery patients.
A two-year peer-reviewed study published in 2022 exploring the mechanism of action of TrueRelief in reducing inflammation and relieving pain.
TrueRelief was awarded a $244,000 federal grant from the Health & Human Services Department to support its development and validation.